Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Rare gene deletions in genetic generalized and Rolandic epilepsies.

Jabbari K, Bobbili DR, Lal D, Reinthaler EM, Schubert J, Wolking S, Sinha V, Motameny S, Thiele H, Kawalia A, Altmüller J, Toliat MR, Kraaij R, van Rooij J, Uitterlinden AG, Ikram MA; EuroEPINOMICS CoGIE Consortium, Zara F, Lehesjoki AE, Krause R, Zimprich F, Sander T, Neubauer BA, May P, Lerche H, Nürnberg P.

PLoS One. 2018 Aug 27;13(8):e0202022. doi: 10.1371/journal.pone.0202022. eCollection 2018.

2.

Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.

van Houten CB, Oved K, Eden E, Cohen A, Engelhard D, Boers S, Kraaij R, Karlsson R, Fernandez D, Gonzalez E, Li Y, Stubbs A, Moore ERB, Hays JP, Bont LJ.

BMC Infect Dis. 2018 Aug 7;18(1):377. doi: 10.1186/s12879-018-3300-9.

3.

Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study.

May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, Iacomino M, Guerrero-López R, Baulac S, Marini C, Thiele H, Altmüller J, Jabbari K, Ruppert AK, Jurkowski W, Lal D, Rusconi R, Cestèle S, Terragni B, Coombs ID, Reid CA, Striano P, Caglayan H, Siren A, Everett K, Møller RS, Hjalgrim H, Muhle H, Helbig I, Kunz WS, Weber YG, Weckhuysen S, Jonghe P, Sisodiya SM, Nabbout R, Franceschetti S, Coppola A, Vari MS, Kasteleijn-Nolst Trenité D, Baykan B, Ozbek U, Bebek N, Klein KM, Rosenow F, Nguyen DK, Dubeau F, Carmant L, Lortie A, Desbiens R, Clément JF, Cieuta-Walti C, Sills GJ, Auce P, Francis B, Johnson MR, Marson AG, Berghuis B, Sander JW, Avbersek A, McCormack M, Cavalleri GL, Delanty N, Depondt C, Krenn M, Zimprich F, Peter S, Nikanorova M, Kraaij R, van Rooij J, Balling R, Ikram MA, Uitterlinden AG, Avanzini G, Schorge S, Petrou S, Mantegazza M, Sander T, LeGuern E, Serratosa JM, Koeleman BPC, Palotie A, Lehesjoki AE, Nothnagel M, Nürnberg P, Maljevic S, Zara F, Cossette P, Krause R, Lerche H; Epicure Consortium; EuroEPINOMICS CoGIE Consortium; EpiPGX Consortium.

Lancet Neurol. 2018 Aug;17(8):699-708. doi: 10.1016/S1474-4422(18)30215-1. Epub 2018 Jul 17.

PMID:
30033060
4.

Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative.

Wang J, Kurilshikov A, Radjabzadeh D, Turpin W, Croitoru K, Bonder MJ, Jackson MA, Medina-Gomez C, Frost F, Homuth G, Rühlemann M, Hughes D, Kim HN; MiBioGen Consortium Initiative, Spector TD, Bell JT, Steves CJ, Timpson N, Franke A, Wijmenga C, Meyer K, Kacprowski T, Franke L, Paterson AD, Raes J, Kraaij R, Zhernakova A.

Microbiome. 2018 Jun 8;6(1):101. doi: 10.1186/s40168-018-0479-3.

5.

Employed family-based genetic discovery combining linkage analysis and exome sequencing to identify RCL1 as a novel candidate gene for depression, with independent replication in a population-based cohort.

Amin N, de Vrij FMS, Baghdadi M, Brouwer RWW, van Rooij JGJ, Jovanova O, Uitterlinden AG, Hofman A, Janssen HLA, Murad SD, Kraaij R, Stedehouder J, van den Hout MCGN, Kros JM, van IJcken WFJ, Tiemeier H, Kushner SA, van Duijn CM.

Mol Psychiatry. 2018 May;23(5):1093. doi: 10.1038/mp.2018.6. No abstract available.

PMID:
29731510
6.

Whole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's Membrane.

Corominas J, Colijn JM, Geerlings MJ, Pauper M, Bakker B, Amin N, Lores Motta L, Kersten E, Garanto A, Verlouw JAM, van Rooij JGJ, Kraaij R, de Jong PTVM, Hofman A, Vingerling JR, Schick T, Fauser S, de Jong EK, van Duijn CM, Hoyng CB, Klaver CCW, den Hollander AI.

Ophthalmology. 2018 Sep;125(9):1433-1443. doi: 10.1016/j.ophtha.2018.03.040. Epub 2018 Apr 26.

7.

Microbiome measurement: Possibilities and pitfalls.

Radjabzadeh D, Uitterlinden AG, Kraaij R.

Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):619-623. doi: 10.1016/j.bpg.2017.10.008. Epub 2017 Oct 31. Review.

PMID:
29566904
8.

Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J; International Parkinson’s Disease Genomics Consortium (IPDGC), Heutink P, Shulman JM.

Brain. 2017 Dec 1;140(12):3191-3203. doi: 10.1093/brain/awx285.

PMID:
29140481
9.

Exome-Wide Meta-Analysis Identifies Rare 3'-UTR Variant in ERCC1/CD3EAP Associated with Symptoms of Sleep Apnea.

van der Spek A, Luik AI, Kocevska D, Liu C, Brouwer RWW, van Rooij JGJ, van den Hout MCGN, Kraaij R, Hofman A, Uitterlinden AG, van IJcken WFJ, Gottlieb DJ, Tiemeier H, van Duijn CM, Amin N.

Front Genet. 2017 Oct 18;8:151. doi: 10.3389/fgene.2017.00151. eCollection 2017.

10.

Population-specific genetic variation in large sequencing data sets: why more data is still better.

van Rooij JGJ, Jhamai M, Arp PP, Nouwens SCA, Verkerk M, Hofman A, Ikram MA, Verkerk AJ, van Meurs JBJ, Rivadeneira F, Uitterlinden AG, Kraaij R.

Eur J Hum Genet. 2017 Oct;25(10):1173-1175. doi: 10.1038/ejhg.2017.110. Epub 2017 Jul 19.

PMID:
28905877
11.

Establishing the role of rare coding variants in known Parkinson's disease risk loci.

Jansen IE, Gibbs JR, Nalls MA, Price TR, Lubbe S, van Rooij J, Uitterlinden AG, Kraaij R, Williams NM, Brice A, Hardy J, Wood NW, Morris HR, Gasser T, Singleton AB, Heutink P, Sharma M; International Parkinson's Disease Genomics Consortium.

Neurobiol Aging. 2017 Nov;59:220.e11-220.e18. doi: 10.1016/j.neurobiolaging.2017.07.009. Epub 2017 Aug 2.

PMID:
28867149
12.

A rare missense variant in RCL1 segregates with depression in extended families.

Amin N, de Vrij FMS, Baghdadi M, Brouwer RWW, van Rooij JGJ, Jovanova O, Uitterlinden AG, Hofman A, Janssen HLA, Darwish Murad S, Kraaij R, Stedehouder J, van den Hout MCGN, Kros JM, van IJcken WFJ, Tiemeier H, Kushner SA, van Duijn CM.

Mol Psychiatry. 2018 May;23(5):1120-1126. doi: 10.1038/mp.2017.49. Epub 2017 Mar 21.

13.

Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population.

Giri A, Mok KY, Jansen I, Sharma M, Tesson C, Mangone G, Lesage S, Bras JM, Shulman JM, Sheerin UM; International Parkinson's Disease Consortium (IPDGC), Díez-Fairen M, Pastor P, Martí MJ, Ezquerra M, Tolosa E, Correia-Guedes L, Ferreira J, Amin N, van Duijn CM, van Rooij J, Uitterlinden AG, Kraaij R, Nalls M, Simón-Sánchez J.

Neurobiol Aging. 2017 Feb;50:167.e11-167.e13. doi: 10.1016/j.neurobiolaging.2016.10.004. Epub 2016 Oct 11.

14.

Nonsynonymous Variation in NKPD1 Increases Depressive Symptoms in European Populations.

Amin N, Belonogova NM, Jovanova O, Brouwer RW, van Rooij JG, van den Hout MC, Svishcheva GR, Kraaij R, Zorkoltseva IV, Kirichenko AV, Hofman A, Uitterlinden AG, van IJcken WF, Tiemeier H, Axenovich TI, van Duijn CM.

Biol Psychiatry. 2017 Apr 15;81(8):702-707. doi: 10.1016/j.biopsych.2016.08.008. Epub 2016 Aug 11.

PMID:
27745872
15.

Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis.

Castaño-Betancourt MC, Evans DS, Ramos YF, Boer CG, Metrustry S, Liu Y, den Hollander W, van Rooij J, Kraus VB, Yau MS, Mitchell BD, Muir K, Hofman A, Doherty M, Doherty S, Zhang W, Kraaij R, Rivadeneira F, Barrett-Connor E, Maciewicz RA, Arden N, Nelissen RG, Kloppenburg M, Jordan JM, Nevitt MC, Slagboom EP, Hart DJ, Lafeber F, Styrkarsdottir U, Zeggini E, Evangelou E, Spector TD, Uitterlinden AG, Lane NE, Meulenbelt I, Valdes AM, van Meurs JB.

PLoS Genet. 2016 Oct 4;12(10):e1006260. doi: 10.1371/journal.pgen.1006260. eCollection 2016 Oct.

16.

Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms.

Amin N, Jovanova O, Adams HH, Dehghan A, Kavousi M, Vernooij MW, Peeters RP, de Vrij FM, van der Lee SJ, van Rooij JG, van Leeuwen EM, Chaker L, Demirkan A, Hofman A, Brouwer RW, Kraaij R, Willems van Dijk K, Hankemeier T, van Ijcken WF, Uitterlinden AG, Niessen WJ, Franco OH, Kushner SA, Ikram MA, Tiemeier H, van Duijn CM.

Mol Psychiatry. 2017 Apr;22(4):634. doi: 10.1038/mp.2016.141. Epub 2016 Aug 9. No abstract available.

PMID:
27502476
17.

Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms.

Amin N, Jovanova O, Adams HH, Dehghan A, Kavousi M, Vernooij MW, Peeters RP, de Vrij FM, van der Lee SJ, van Rooij JG, van Leeuwen EM, Chaker L, Demirkan A, Hofman A, Brouwer RW, Kraaij R, Willems van Dijk K, Hankemeier T, van Ijcken WF, Uitterlinden AG, Niessen WJ, Franco OH, Kushner SA, Ikram MA, Tiemeier H, van Duijn CM.

Mol Psychiatry. 2017 Apr;22(4):537-543. doi: 10.1038/mp.2016.101. Epub 2016 Jul 19. Erratum in: Mol Psychiatry. 2017 Apr;22(4):634.

PMID:
27431295
18.

Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2.

van den Akker EB, Pitts SJ, Deelen J, Moed MH, Potluri S, van Rooij J, Suchiman HE, Lakenberg N, de Dijcker WJ, Uitterlinden AG, Kraaij R, Hofman A, de Craen AJ, Houwing-Duistermaat JJ, van Ommen GJ; Genome of The Netherlands Consortium, Cox DR, van Meurs JB, Beekman M, Reinders MJ, Slagboom PE.

Blood. 2016 Mar 17;127(11):1512-5. doi: 10.1182/blood-2015-12-685925. Epub 2016 Jan 29. No abstract available.

19.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

20.

Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture.

Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A, Leo PJ, Dahia CL, Park-Min KH, Tobias JH, Kooperberg C, Kleinman A, Styrkarsdottir U, Liu CT, Uggla C, Evans DS, Nielson CM, Walter K, Pettersson-Kymmer U, McCarthy S, Eriksson J, Kwan T, Jhamai M, Trajanoska K, Memari Y, Min J, Huang J, Danecek P, Wilmot B, Li R, Chou WC, Mokry LE, Moayyeri A, Claussnitzer M, Cheng CH, Cheung W, Medina-Gómez C, Ge B, Chen SH, Choi K, Oei L, Fraser J, Kraaij R, Hibbs MA, Gregson CL, Paquette D, Hofman A, Wibom C, Tranah GJ, Marshall M, Gardiner BB, Cremin K, Auer P, Hsu L, Ring S, Tung JY, Thorleifsson G, Enneman AW, van Schoor NM, de Groot LC, van der Velde N, Melin B, Kemp JP, Christiansen C, Sayers A, Zhou Y, Calderari S, van Rooij J, Carlson C, Peters U, Berlivet S, Dostie J, Uitterlinden AG, Williams SR, Farber C, Grinberg D, LaCroix AZ, Haessler J, Chasman DI, Giulianini F, Rose LM, Ridker PM, Eisman JA, Nguyen TV, Center JR, Nogues X, Garcia-Giralt N, Launer LL, Gudnason V, Mellström D, Vandenput L, Amin N, van Duijn CM, Karlsson MK, Ljunggren Ö, Svensson O, Hallmans G, Rousseau F, Giroux S, Bussière J, Arp PP, Koromani F, Prince RL, Lewis JR, Langdahl BL, Hermann AP, Jensen JE, Kaptoge S, Khaw KT, Reeve J, Formosa MM, Xuereb-Anastasi A, Åkesson K, McGuigan FE, Garg G, Olmos JM, Zarrabeitia MT, Riancho JA, Ralston SH, Alonso N, Jiang X, Goltzman D, Pastinen T, Grundberg E, Gauguier D, Orwoll ES, Karasik D, Davey-Smith G; AOGC Consortium, Smith AV, Siggeirsdottir K, Harris TB, Zillikens MC, van Meurs JB, Thorsteinsdottir U, Maurano MT, Timpson NJ, Soranzo N, Durbin R, Wilson SG, Ntzani EE, Brown MA, Stefansson K, Hinds DA, Spector T, Cupples LA, Ohlsson C, Greenwood CM; UK10K Consortium, Jackson RD, Rowe DW, Loomis CA, Evans DM, Ackert-Bicknell CL, Joyner AL, Duncan EL, Kiel DP, Rivadeneira F, Richards JB.

Nature. 2015 Oct 1;526(7571):112-7. doi: 10.1038/nature14878. Epub 2015 Sep 14.

21.

Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer.

Schenk E, Essand M, Kraaij R, Adamson R, Maitland NJ, Bangma CH.

Hum Gene Ther Clin Dev. 2014 Mar;25(1):7-15. doi: 10.1089/humc.2013.181.

PMID:
24649837
22.

Pre-clinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer.

Schenk E, Essand M, Kraaij R, Adamson R, Maitland N, Bangma CH.

Hum Gene Ther Clin Dev. 2014 Feb 18. [Epub ahead of print]

PMID:
24548052
23.

Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium.

Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, Hansen M, Borecki IB, Cupples LA, Fornage M, Gudnason V, Harris TB, Kathiresan S, Kraaij R, Launer LJ, Levy D, Liu Y, Mosley T, Peloso GM, Psaty BM, Rich SS, Rivadeneira F, Siscovick DS, Smith AV, Uitterlinden A, van Duijn CM, Wilson JG, O'Donnell CJ, Rotter JI, Boerwinkle E.

PLoS One. 2013 Jul 12;8(7):e68095. doi: 10.1371/journal.pone.0068095. Print 2013.

24.

Evaluating baculovirus as a vector for human prostate cancer gene therapy.

Swift SL, Rivera GC, Dussupt V, Leadley RM, Hudson LC, Ma de Ridder C, Kraaij R, Burns JE, Maitland NJ, Georgopoulos LJ.

PLoS One. 2013 Jun 6;8(6):e65557. doi: 10.1371/journal.pone.0065557. Print 2013.

25.

Tumor protection by IL-7 secreting whole cell vaccine is merely mediated by NK1.1-positive cells.

Schroten C, Scheffer R, Boon L, de Ridder CM, Bangma CH, Kraaij R.

J Immunother. 2012 Feb-Mar;35(2):125-30. doi: 10.1097/CJI.0b013e318242514b.

PMID:
22306900
26.

The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.

Schroten C, Dits NF, Steyerberg EW, Kranse R, van Leenders AG, Bangma CH, Kraaij R.

Cancer Immunol Immunother. 2012 Jun;61(6):905-10. doi: 10.1007/s00262-011-1159-3. Epub 2011 Nov 24.

27.

A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.

Magnusson MK, Kraaij R, Leadley RM, De Ridder CM, van Weerden WM, Van Schie KA, Van der Kroeg M, Hoeben RC, Maitland NJ, Lindholm L.

Hum Gene Ther. 2012 Jan;23(1):70-82. doi: 10.1089/hum.2011.016. Epub 2011 Oct 12.

28.

Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.

Schäfer A, Pahnke A, Schaffert D, van Weerden WM, de Ridder CM, Rödl W, Vetter A, Spitzweg C, Kraaij R, Wagner E, Ogris M.

Hum Gene Ther. 2011 Dec;22(12):1463-73. doi: 10.1089/hum.2010.231. Epub 2011 Aug 10.

29.

Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.

de Vrij J, van den Hengel SK, Uil TG, Koppers-Lalic D, Dautzenberg IJ, Stassen OM, Bárcena M, Yamamoto M, de Ridder CM, Kraaij R, Kwappenberg KM, Schilham MW, Hoeben RC.

Virology. 2011 Feb 5;410(1):192-200. doi: 10.1016/j.virol.2010.10.040. Epub 2010 Dec 4.

30.

T cell activation upon exposure to patient-derived tumor tissue: a functional assay to select patients for adoptive T cell therapy.

Schroten C, Kraaij R, Veldhoven JL, Berrevoets CA, den Bakker MA, Ma Q, Sadelain M, Bangma CH, Willemsen RA, Debets R.

J Immunol Methods. 2010 Jul 31;359(1-2):11-20. doi: 10.1016/j.jim.2010.04.006. Epub 2010 May 9.

PMID:
20460126
31.

Gene transfer vectors targeted to human prostate cancer: do we need better preclinical testing systems?

Maitland N, Chambers K, Georgopoulos L, Simpson-Holley M, Leadley R, Evans H, Essand M, Danielsson A, van Weerden W, de Ridder C, Kraaij R, Bangma CH; GIANT FP6 Consortium.

Hum Gene Ther. 2010 Jul;21(7):815-27. doi: 10.1089/hum.2009.210. Review.

PMID:
20030557
32.

Clinical adenoviral gene therapy for prostate cancer.

Schenk E, Essand M, Bangma CH; GIANT FP6 Consortium, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Danielsson A, Dautzenberg IJ, Dzojic H, Erbacher P, Fisher K, Frazier A, Georgopoulos LJ, Hoeben R, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Lindholm L, Magnusson M, Maitland N, Neuberg P, Nilsson B, Ogris M, Remy JS, Scaife M, Schooten E, Seymour L, Totterman T, Uil TG, Ulbrich K, Veldhoven-Zweistra JL, de Vrij J, van Weerden W, Wagner E, Willemsen R.

Hum Gene Ther. 2010 Jul;21(7):807-13. doi: 10.1089/hum.2009.206. Review.

PMID:
20001452
33.

Adenovirus-derived vectors for prostate cancer gene therapy.

de Vrij J, Willemsen RA, Lindholm L, Hoeben RC; GIANT Consortium, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G.

Hum Gene Ther. 2010 Jul;21(7):795-805. doi: 10.1089/hum.2009.203. Review.

PMID:
19947826
34.

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, Boormans JL, van der Kwast TH, van Dekken H, Bangma CH, Korsten H, Kraaij R, Jenster G, Trapman J.

Cancer Res. 2008 Sep 15;68(18):7541-9. doi: 10.1158/0008-5472.CAN-07-5930.

35.

Longer guts and higher food quality increase energy intake in migratory swans.

van Gils JA, Beekman JH, Coehoorn P, Corporaal E, Dekkers T, Klaassen M, van Kraaij R, de Leeuw R, de Vries PP.

J Anim Ecol. 2008 Nov;77(6):1234-41. doi: 10.1111/j.1365-2656.2008.01452.x. Epub 2008 Jul 25.

PMID:
18662243
36.

A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy.

Schroten-Loef C, de Ridder CM, Reneman S, Crezee M, Dalgleish A, Todryk SM, Bangma CH, Kraaij R.

Cancer Immunol Immunother. 2009 Mar;58(3):373-81. doi: 10.1007/s00262-008-0560-z. Epub 2008 Jul 19.

PMID:
18641982
37.

A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.

Kraaij R, van der Weel L, de Ridder CM, van der Korput HA, Zweistra JL, van Rijswijk AL, Bangma CH, Trapman J.

Prostate. 2007 Jun 1;67(8):829-39.

PMID:
17394196
38.

Gene therapy in urology: strategies to translate theory into practice.

Bangma CH, Mongiat P, Kraaij R, Schenk-Braat E.

BJU Int. 2005 Dec;96(8):1163-70. Review. No abstract available.

39.

Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.

Lipinski KS, Pelech S, Mountain A, Irvine AS, Kraaij R, Bangma CH, Mills KH, Todryk SM.

Cancer Immunol Immunother. 2006 Mar;55(3):347-54. Epub 2005 Jun 17.

PMID:
16075195
40.

Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.

van der Linden RR, Haagmans BL, Mongiat-Artus P, van Doornum GJ, Kraaij R, Kadmon D, Aguilar-Cordova E, Osterhaus AD, van der Kwast TH, Bangma CH.

Eur Urol. 2005 Jul;48(1):153-61. Epub 2005 Mar 9.

PMID:
15967266
41.

Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.

Kraaij R, van Rijswijk AL, Oomen MH, Haisma HJ, Bangma CH.

Prostate. 2005 Feb 15;62(3):253-9.

PMID:
15389777
42.

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer.

Cheng WS, Kraaij R, Nilsson B, van der Weel L, de Ridder CM, Tötterman TH, Essand M.

Mol Ther. 2004 Aug;10(2):355-64.

43.

Bioavailability in soil or sediment: exposure of different organisms and approaches to study it.

Sijm D, Kraaij R, Belfroid A.

Environ Pollut. 2000 Apr;108(1):113-9.

PMID:
15092972
44.

Slow desorption of PCBs and chlorobenzenes from soils and sediments: relations with sorbent and sorbate characteristics.

Cornelissen G, Hassell KA, van Noort PC, Kraaij R, van Ekeren PJ, Dijkema C, de Jager PA, Govers HA.

Environ Pollut. 2000 Apr;108(1):69-80.

PMID:
15092968
45.

Measured pore-water concentrations make equilibrium partitioning work--a data analysis.

Kraaij R, Mayer P, Busser FJ, van het Bolscher M, Seinen W, Tolls J, Belfroid AC.

Environ Sci Technol. 2003 Jan 15;37(2):268-74.

PMID:
12564897
46.

Adenoviral mediated gene therapy for prostate cancer: studies on vector tropism and payload.

Bangma CH, Kraaij R, Oomen MH, Th Van Rijswijk AL, De Ridder CM.

Prostate Cancer Prostatic Dis. 2000 Dec;3(S1):S5. No abstract available.

47.

Transductional targeting of adenoviral vectors to prostate cancer in vitro.

Bangma CH, Kraaij R, Van Rijswijk A, Haisma HJ, Van Beusechem V, Gerritsen W.

Prostate Cancer Prostatic Dis. 1999 Nov;2(S3):S5. No abstract available.

48.

Direct evidence of sequestration in sediments affecting the bioavailability of hydrophobic organic chemicals to benthic deposit-feeders.

Kraaij R, Seinen W, Tolls J, Cornelissen G, Belfroid AC.

Environ Sci Technol. 2002 Aug 15;36(16):3525-9.

PMID:
12214644
49.

Effects of contact time on the sequestration and bioavailability of different classes of hydrophobic organic chemicals to benthic oligochaetes (Tubificidae).

Kraaij RH, Tolls J, Sum D, Cornelissen G, Heikens A, Belfroid A.

Environ Toxicol Chem. 2002 Apr;21(4):752-9.

PMID:
11951948
50.

Validation of transrectal ultrasonographic volumetry for orthotopic prostate tumours in mice.

Kraaij R, van Weerden WM, de Ridder CM, Gussenhoven EJ, Honkoop J, Nasu Y, Bangma CH.

Lab Anim. 2002 Apr;36(2):165-72.

PMID:
11943081

Supplemental Content

Loading ...
Support Center